Philip Morris
New Study Says Breast Implants Are Not A Health Risk
Fields
- Author
- Joyce, C.
- Area
- NICOLI,DAVID/OFFICE
- Type
- TRAN, TRANSCRIPT
- COMP, COMPUTER PRINTOUT
- Attachment
- 2046936874/2046936876
- Named Organization
- FDA, Food and Drug Administration
- Mayo Clinic
- Morning Edition
- New England Journal of Medicine
- Boston Univ
- Dow Corning
- Emory Univ
- Mayo Clinic
- Named Person
- Annis, G.
- Connell, E.
- Hugo, M.
- Edwards, R.
- Connell, E.
- Document File
- 2046936725/2046937271/Missing
- Request
- Stmn/R1-072
- Stmn/R1-079
- Litigation
- Stmn/Produced
- Author (Organization)
- Lexis Nexis
- Mead Data Central
- Natl Public Radio
- Mead Data Central
- Master ID
- 2046936726/6992
Related Documents:- 2046936726 Table of Contents
- 2046936727 A
- 2046936728-6731 FDA's Legally Suspect Actions Invite Challenge
- 2046936732-6735 FDA Paralysis Raises Health Care Costs
- 2046936736-6739 the Real Problem with Health Care in America: While Dr. David Kessler's FDA Fiddles, Medical Approvals Lag and Americans Die
- 2046936740-6743 What the FDA Doesn't Want You to Know Could Kill You
- 2046936744-6751
- 2046936752-6759
- 2046936760-6762 Guide to Medical Device Regulation FDA Issues First Warning Letter Citing Gmp Problems Under New Cpg
- 2046936763-6766 the Vitamin Uprising
- 2046936767-6780 Losing the Edge Overseas Patients Reap the Benefits of U.S.Research While Those Here Wait
- 2046936781-6783 Losing the Edge
- 2046936784 Feds: Toughen Regulation, Promote Research Improvements Needed, and They Are on the Way
- 2046936785-6786
- 2046936787-6789 Challenging FDA Authority
- 2046936790-6793 Speakeasies in A New Age of Prohibition
- 2046936794-6798 Who Is Happiest Politician in Washington Over Whitewater? Alfonse D'amato - Newt Gingrich - David Kessler?
- 2046936799-6800 Pro-Free Enterprise Group Challenges FDA's Authority to Regulate Drug Companies' Speech
- 2046936801-6802 Wlf Off-Label Use Suit Heats Up
- 2046936803-6805 Just Call Me 'doc'
- 2046936806-6810 Food and Drugs and Politics
- 2046936811-6813 Science and Technology Getting the Lead Out
- 2046936814 Forbes Fear of Falling 5 Ways to Protect Yourself in Scary Times
- 2046936815-6816 Book Burning
- 2046936817 If A Murderer Kills You, It's Homicide If A Drunk Driver Kills You, It's Manslaughter If the FDA Kills You, It's Just Being Cautious
- 2046936818-6820 Frustration for Medical Innovators
- 2046936821 Block That Innovation
- 2046936822-6823 Getting Even
- 2046936824-6826 Biotech Pipeline: Bottleneck Ahead
- 2046936827-6829 Consuming Interest Are We Safe From the FDA?
- 2046936830-6839 Saying Yes to Drugs Policy Analysis
- 2046936840-6858 Deadly Overcaution: FDA's Drug Approval Process
- 2046936859 B
- 2046936860-6861 Litigation Update Wlf Wins Suit Against FDA to Stop Overregulation of Heart Valves (Washington Legal Foundation V. Shalala)
- 2046936862-6863 Litigation Update Wlf Opposes FDA Efforts to Dismiss First Amendment Lawsuit (Washington Legal Foundation V. Kessler)
- 2046936864-6867 Dickinson's FDA Review
- 2046936868-6869 Wlf Urges Appeals Court to Enjoin Federal Policy Restricting Human Heart Valve Transplant (Washington Legal Foundation V. Shalala)
- 2046936870-6871 FDA Problems Slow US Andas
- 2046936872-6873 Taking the Heat An Aids Patient Champions A Risky Blood Treatment Banned in the U.S.
- 2046936877-6878 Wlf Sues FDA to Overturn Policy Restricting Information on Off-Labels Uses of Approved Drugs and Devices (Washington Legal Foundation V. Shalala)
- 2046936879 Ex-Inspector of F.D.A. Is Convicted of Bribery
- 2046936879A FDA Has No Position Yet
- 2046936880-6881 M-D-D-I Reports - 'the Gray Sheet'
- 2046936882 FDA Halts Test on Device That Shows Promise for the Victims of Cardiac Arrest
- 2046936883 Law Concerning Medical Devices Is Often Ignored
- 2046936884 Dairies, Drugs and Accusations
- 2046936884A FDA to Launch Campaign on New Labels for Food
- 2046936885 Probe of Three FDA Officials Sought Industry Ties Before Approval of Bovine Growth Hormone Are at Issue
- 2046936886-6889 Safety First How A Device to Aid in Breast Self-Exams If Kept Off the Market Other Nations Approved It But U.S. Demands Proof Simple Pad Isn't Risky Nine Year Battle with the FDA
- 2046936890-6892 Who Will Regulate the Regulators? If You Make A Mistake, Shouldn't You Own Up? Not If You're the FDA, Epa, or Ftc
- 2046936893-6894 None - A - Day Is the FDA Out to Take Your Vitamin?
- 2046936895 Will A New Government Program Net the Bad Fish?
- 2046936896-6897 FDA Responds to Wlf Petition Regarding Off-Label Drug Use by Indefinitely Postponing Issuance of Regulatory Guidelines
- 2046936898-6905 FDA Research: Overview
- 2046936906-6910 Government Report Finds Levels Safe Pesticide Residues in Your Children's Food
- 2046936911-6912 Wlf Urges FDA to Rescind Policy Restricting Information Flow on Off-Label Uses of Approved Drugs and Devices
- 2046936913 Regulatory Chokehold FDA Red Tape Dooms Transplant Drug
- 2046936914 FDA Called Lax in Overseeing Medical Sterilizers, Disinfectants
- 2046936915 FDA Sets Labeling Rules for Dietary Supplements Nutritional Data, Support for Health Claims Required
- 2046936916 Chemicals That Taint Seafood Concerns Continue Over Safety of Methylmercury Inspection Processes
- 2046936917 Lifesaving Devices Languish at the FDA
- 2046936918-6919 Wlf Sues FDA to Enjoin Federal Policy Restricting Human Heart Valve Transplants (Washington Legal Foundation V. Shalala)
- 2046936920 What's in Food? Answers Differ at 2 Agencies Manufacturers Fight to Keep FDA Label Rules From Encroaching on Ftc Ad Rules
- 2046936921 Reform the FDA
- 2046936922 Legal Beat FDA Approval Shield Firms in Injury Suits
- 2046936923 Water From A Bottle
- 2046936924 Commentary FDA and Our Split Medical Persona
- 2046936925-6926 FDA Assailed for Slow Testing of New Drugs
- 2046936927 Andrews Office Products Capitol Heights, Md (K)
- 2046936928-6947 Statement by David A. Kessler, M.D. Commissioner of Food and Drugs Before the Committee on Energy and Commerce Subcommittee on Health and the Environment U.S. House of Representatives
- 2046936948-6961 Filthy Food,Dubious Drugs, and Defective Devices: the Legacy of FDA's Antiquated Statute A Staff Report
- 2046936962-6968 Gao Reports on FDA-Related Topics 860000 to Present
- 2046936969 D
- 2046936970-6985 Statement by Louis W. Sullivan, M.D. Secretary of Health and Human Services Before the Committee on Labor and Human Resources U.S. Senate on the Final Report of the Advisory Committee on the FDA
- 2046936986-6992 Proposed Remarks of Dr. Charles Edwards Before the Senate Committee on Labor and Human Resources
- Characteristic
- MISS, MISSING PAGES
- Site
- W6
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- bnt92e00
Document Images
Page 2
LEVEL 1- 1 OF 4 STORIES
Copyright 1994 National Public Radio
NPR
SHOW: Morning Edition (NPR 6:00 am ET)
June 16, 1994
Transcript # 1369-2
TYPE: Package
SECTION: News; Domestic
LENGTH: 901 words
HEADLINE: New Study Says Breast Implants are Not a Health Risk
GUESTS: ELIZABETH CONNELL, Physician, Emory University; MICHAEL HUGO, Lawyer
Representing Women Suing Over Breast Implants; GEORGE ANNIS, Attorney, Boston
University's Medical School
BYLINE: CHRISTOPHER JOYCE
HIGHLIGHT:
Just one day before women suing breast implant makers must decide whether or not
to accept a settlement, the "New England Journal of Medicine" issued a report
stating breast implants do not pose a health risk.
BODY:
BOB EDWARDS, Host: A study reported in today's New England Journal of
Medicine raises questions about the dangers of silicone breast implants. The
study finds no link between the implants and many of the diseases commonly
associated with the device. The report comes at a crucial time. Tomorrow,
women who have sued implant makers must choose whether to stay in court or
accept a cash settlement. NPR's Christopher Joyce examines how this study could
affect their decision and breast implant regulations.
CHRISTOPHER JOYCE, Reporter: Silicone breast implants were once considered a
breakthrough for women who had lost a breast to surgery or who wanted to change
the way they looked. But, then women began to complain that the implants were
making them seriously ill. Lawsuits against the manufacturers followed, the
Food and Drug Administration stepped in and, in 1992, decided that women could
only get silicone implants as part of a study, to see if they were safe.
Physician Elizabeth Connell, of Emory University, headed a committee that
advised the FDA on implants. There was very little research on silicone
implants and disease at the time.
ELIZABETH CONNELL, Physician, Emory University: We did not have really any good
evidence. We had large amounts of anecdotal material, but, the bottom line was
that there was no clear evidence of an association.
~.EXIS~ NEXISp= ~= LEXIS~~ NEX1S ==_ LEXIS ~ NEX15~===
Servrces of Mead Data Central, tnc.

i
Morning Edition (NPR), June 16, 1994
Page 3
JOYCE: The FDA decided to restrict access to implants anyway because they
couldn't be sure there wasn't a danger to women. Today's study by scientists at
the Mayo Clinic is the first large-scale examination of implants and connective
tissue disease, such as arthritis, rheumatism, and various skin disorders. It
found no link between implants and these diseases in more than 700 women
studied. Connell says the Mayo Clinic's findings would have been helpful back
in 1992, but, she says more still needs to be done.
Dr. CONNELL: You know, it takes more than one swallow to make a summer, and I
would view this as a first step toward the accumulation of a number of studies
looking at these issues, perhaps with slightly different design- different
subjects. I don't think this in itself is gonna make a quantum change in the
FDA position.
JOYCE: But, the study could influence thousands of women suing implant
manufacturers. Earlier this year, Dow Corning Company, and other silicone
implant manufacturers, said they'd rather pay than fight, and set up a $4.2
billion fund to pay off plaintiffs. Women can choose to get money now or
continue to sue.
MICHAEL HUGO, Lawyer Representing Women Suing Over Breast Implants: At this
time, before tomorrow's deadline for opting out of the settlement, I think that
there are approximately 20,000 cases pending.
JOYCE: That's Michael Hugo [sp], a lawyer who represents some of the estimated
20,000 women whose lawsuits over silicone implants are still pending. He's
worried about how women will respond to the study.
[interviewing] Do you think that the findings in this scientific paper will
encourage women to go into the settlement instead of fight it in the courts?
Mr. HUGO: If they're not informed as to what the findings truly are, yes.
JOYCE: Hugo says the study isn't as strong as it first may appear. He says it
was based on limited information and didn't follow women's health for long
enough. The New England Journal defends the study, noting that it was examined
by three outside experts before being published, and is the best study to
examine safety of silicone implants to date. And a researcher who spent years
studying implants and skin disease says the Mayo Clinic's work confirms her own
findings - no cause and effect from implants.
But, the fate of silicone implants is being played out in more courtrooms than
in laboratories, and the study has flaws that will limit its usefulness in ~
court, says George Annis [sp], a lawyer who specializes in health issues at p
Boston University's Medical School. Fp,
~
GEORGE ANNIS, Attorney, Boston University's Medical School: Number one, the C~
methodology of the study itself is limited. W
C7)
JOYCE: That's because it's retroactive. It simply looks back at women's medical 00
histories. A kind of study scientists view as valid, but weak. Then there's _J
the fact that a plastic surgeon's group helped fund the study. VT
~ NEXIS~= =~ LEXIS~ NEX1S~= ~= LEXIS~ NEXIS@ =~_
~.EX1S
Services of Mead Data Central, )nc.

V
ti
!
Morning Edition (NPR), June 16, 1994
Page 4
Mr. ANNIS: Number two, the fact that it was funded by the plastic surgeons is,
of course, going to call its validity into question.
JOYCE: Not because scientists are easily bought necessarily, but, because it
casts doubt in the minds of judges and juries.
Mr. ANNIS: And, third, the legal system doesn't see any one study as definitive,
just another thing to argue about.
JOYCE: Meanwhile, more studies are underway, and the FDA will continue to
evaluate evidence about the safety of silicone implants, and whether its
decision to limit their availability was correct. In Washington, I'm
Christopher Joyce.
[music]
EDWARDS: The time is 19 minutes past the hour.
['All Things Considered' promo]
[music]
[news headlines]
[music]
The preceding text has been professionally transcribed. However, although
the text has been checked against an audio track, in order to meet rigid
distribution and transmission deadlines, it may not have been proofread against
tape.
LANGUAGE: ENGLISH
LOAD-DATE-MDC: June 16, 1994
~EXIS~ NEXIS == TM LEXIS~ NEXIS =~ _
LEXIS" NEXIS =~_
Senrrces ot Mead Data CentraJ, Jnc.
